Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine plus butorphanol for depression and pain after cesarean section
ChiCTR2200062785Phase 4Not yet recruiting
- Sponsor
- Dazhu County People's Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain and postpartum depression (PPD) comparing Esketamine + butorphanol with Butorphanol alone (2 arms). Primary endpoint: MBS score. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
esketaminebutorphanol
03
Conditions
postoperative painpostpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2200062785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062785.